BC Innovations | Sep 25, 2014
Cover Story

Interrupting Ebola

The 2014 Ebola outbreak is the largest in the disease's history and the first in West Africa, where it has reached multiple countries. Although an approved therapy looks far away, five of seven patients given...
BioCentury | Sep 15, 2014
Product Development

Ebola realities

Hope that experimental Ebola vaccines and therapies might help contain the current outbreak is sliding into hype as public health officials exaggerate how quickly new products could be deployed and minimize the uncertainties inherent in...
BC Innovations | Nov 21, 2013
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Ebola virus Ebola glycoprotein GP1; Ebola glycoprotein GP2 Primate studies suggest combining anti-Ebola antibodies plus interferon-a (IFNA; IFN-a) could help...
BC Innovations | Jul 26, 2012
Targets & Mechanisms

Target on Ebola

Public Health Agency of Canada researchers have shown that a cocktail of three antibodies, dubbed ZMab , improved the survival of nonhuman primates infected by Ebola virus. 1 ZMab is licensed to Defyrus Inc. , which plans...
Items per page:
1 - 4 of 4